{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:50:57Z","timestamp":1791305457824,"version":"4.3.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100013173","name":"Gyeonggi-do Regional Research Center","doi-asserted-by":"publisher","award":["GRRCAjou2023-B03"],"award-info":[{"award-number":["GRRCAjou2023-B03"]}],"id":[{"id":"10.13039\/501100013173","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s11095-026-04175-4","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:50:26Z","timestamp":1787316626000},"page":"3273-3286","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comprehensive Analytical Characterization of mRNA Influenza Vaccine Under Stress Conditions: Implications for Stability and Quality Control"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-0906-0415","authenticated-orcid":false,"given":"Jiyoun","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyoung","family":"Sim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seulgi","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyoung","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunji","family":"Kum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyewon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inyoung","family":"Huh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaeseung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeon-Jung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byoungju","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeungwoon","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Duk","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,21]]},"reference":[{"key":"4175_CR1","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1126\/science.1690918","volume":"247","author":"JA Wolff","year":"1990","unstructured":"Wolff JA, Malone RW, Williams P, Chong W, Acsadi G, Jani A, Felgner PL. Direct gene transfer into mouse muscle in vivo. Science. 1990;247:1465\u20138. https:\/\/doi.org\/10.1126\/science.1690918.","journal-title":"Science"},{"key":"4175_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01007-w","volume":"7","author":"S Qin","year":"2022","unstructured":"Qin S, Tang X, Chen Y, et al. mRNA-based therapeutics: powerful and versatile tools to combat diseases. Sig Transduct Target Ther. 2022;7: 166.","journal-title":"Sig Transduct Target Ther"},{"issue":"27","key":"4175_CR3","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, P\u00e9rez Marc G, Moreira ED, Zerbini C, Bailey R, Swanson KA, Roychoudhury S, Koury K, Li P, Kalina WV, Cooper D, Frenck RW Jr, Hammitt LL, T\u00fcreci \u00d6, Nell H, Schaefer A, \u00dcnal S, Tresnan DB, Mather S, Dormitzer PR, \u015eahin U, Jansen KU, Gruber WC. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383(27):2603\u201315. https:\/\/doi.org\/10.1056\/NEJMoa2034577.","journal-title":"N Engl J Med"},{"key":"4175_CR4","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/s41586-020-2622-0","volume":"586","author":"KS Corbett","year":"2020","unstructured":"Corbett KS, Edwards DK, Leist SR, et al. SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness. Nature. 2020;586:567\u201371. https:\/\/doi.org\/10.1038\/s41586-020-2622-0.","journal-title":"Nature"},{"key":"4175_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.biotechadv.2020.107534","author":"Y Weng","year":"2020","unstructured":"Weng Y, Li C, Yang T, Hu B, Zhang M, Guo S, Xiao H, Liang X-J, Huang Y. The challenge and prospect of mRNA therapeutics landscape. Biotechnol Adv. 2020. https:\/\/doi.org\/10.1016\/j.biotechadv.2020.107534.","journal-title":"Biotechnol Adv"},{"key":"4175_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02634-x","volume":"22","author":"Z Iqbal","year":"2024","unstructured":"Iqbal Z, Rehman K, Mahmood A, Shabbir M, Liang Y, Duan L, Zeng H. Exosome for mRNA delivery: strategies and therapeutic applications. J Nanobiotechnology. 2024;22: 395.","journal-title":"J Nanobiotechnology"},{"issue":"11","key":"4175_CR7","doi-asserted-by":"publisher","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","volume":"15","author":"R Tenchov","year":"2021","unstructured":"Tenchov R, Bird R, Curtze AE, Zhou Q. Lipid nanoparticles\u2500from liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement. ACS Nano. 2021;15(11):16982\u20137015.","journal-title":"ACS Nano"},{"key":"4175_CR8","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3390\/vaccines9010065","volume":"9","author":"MD Buschmann","year":"2021","unstructured":"Buschmann MD, Carrasco MJ, Alishetty S, Paige M, Alameh MG, Weissman D. Nanomaterial delivery systems for mRNA vaccines. Vaccines. 2021;9:65.","journal-title":"Vaccines"},{"issue":"2","key":"4175_CR9","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3390\/vaccines13020097","volume":"13","author":"C Anastassopoulou","year":"2025","unstructured":"Anastassopoulou C, Medi\u0107 S, Ferous S, Boufidou F, Tsakris A. Development, current status, and remaining challenges for respiratory syncytial virus vaccines. Vaccines (Basel). 2025;13(2):97.","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"4175_CR10","doi-asserted-by":"publisher","first-page":"2484088","DOI":"10.1080\/21645515.2025.2484088","volume":"21","author":"B Kandinov","year":"2025","unstructured":"Kandinov B, Soens M, Huang W, Llapur C, Ensz D, Essink B, Fierro C, Vakil J, Pucci A, Guo J, Rudden S, Hall K, Hicks B, Schaefers K, Zhou H, Ma C, Zheng L, Avanesov A, Park Y, Du E, Miller J, Ananworanich J, Nachbagauer R. An mRNA-based seasonal influenza vaccine in adults: results of two phase 3 randomized clinical trials and correlate of protection analysis of hemagglutination inhibition titers. Hum Vaccines Immunother. 2025;21(1):2484088.","journal-title":"Hum Vaccines Immunother"},{"issue":"6","key":"4175_CR11","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1056\/NEJMoa1700153","volume":"377","author":"ML Jackson","year":"2015","unstructured":"Jackson ML, Chung JR, Jackson LA, Phillips CH, Benoit J, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman R, Nowalk MP, Fry AM, Flannery B. Influenza vaccine effectiveness in the United States during the 2015\u20132016 season. N Engl J Med. 2015;377(6):534\u201343.","journal-title":"N Engl J Med"},{"key":"4175_CR12","doi-asserted-by":"publisher","unstructured":"Ohmit SE, Thompson MG, Petrie JG, Thaker SN, Jackson ML, Belongia EA, et al. Influenza vaccine effectiveness in the 2011\u20132012 season: protection against each circulating virus and the effect of prior vaccination on estimates. Clin Infect Dis. 2011. https:\/\/doi.org\/10.1093\/cid\/cit736.","DOI":"10.1093\/cid\/cit736"},{"issue":"6","key":"4175_CR13","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41577-019-0143-6","volume":"19","author":"F Krammer","year":"2019","unstructured":"Krammer F. The human antibody response to influenza A virus infection and vaccination. Nat Rev Immunol. 2019;19(6):383\u201397.","journal-title":"Nat Rev Immunol"},{"key":"4175_CR14","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrd.2017.243","volume":"17","author":"N Pardi","year":"2018","unstructured":"Pardi N, Hogan MJ, Porter FW, Weissman D. mRNA vaccines \u2014 a new era in vaccinology. Nat Rev Drug Discov. 2018;17:261\u201379.","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"4175_CR15","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1080\/14760584.2024.2354251","volume":"23","author":"C Hu","year":"2024","unstructured":"Hu C, Bai Y, Liu J, Wang Y, He Q, Zhang X, Cheng F, Xu M, Mao Q, Liang Z. Research progress on the quality control of mRNA vaccines. Expert Rev Vaccines. 2024;23(1):570\u201383.","journal-title":"Expert Rev Vaccines"},{"issue":"1","key":"4175_CR16","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.xphs.2019.09.018","volume":"109","author":"J Halley","year":"2020","unstructured":"Halley J, Chou YR, Cicchino C, Huang M, Sharma V, Tan NC, Thakkar S, Zhou LL, Al-Azzam W, Cornen S, Gauden M, Gu Z, Kar S, Lazar AC, Mehndiratta P, Smith J, Sosic Z, Weisbach P, Stokes ESE. An industry perspective on forced degradation studies of biopharmaceuticals: survey outcome and recommendations. J Pharm Sci. 2020;109(1):6\u201321.","journal-title":"J Pharm Sci"},{"issue":"3","key":"4175_CR17","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.ymeth.2012.01.001","volume":"57","author":"SC De Rosa","year":"2012","unstructured":"De Rosa SC. Vaccine applications of flow cytometry. Methods. 2012;57(3):383\u201391.","journal-title":"Methods"},{"issue":"2","key":"4175_CR18","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3390\/vaccines9020081","volume":"9","author":"I Knezevic","year":"2021","unstructured":"Knezevic I, Liu MA, Peden K, Zhou T, Kang HN. Development of mRNA Vaccines: Scientific and Regulatory Issues. Vaccines (Basel). 2021;9(2):81.","journal-title":"Vaccines (Basel)"},{"key":"4175_CR19","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1002\/elps.202100244","volume":"43","author":"C Kinsey","year":"2022","unstructured":"Kinsey C, Lu T, Deiss A, Vuolo K, Klein L, Rustandi RR, Loughney JW. Determination of lipid content and stability in lipid nanoparticles using ultra high-performance liquid chromatography in combination with a Corona Charged Aerosol Detecto2. Electrophoresis. 2022;43:1091\u2013100.","journal-title":"Electrophoresis"},{"issue":"1","key":"4175_CR20","doi-asserted-by":"publisher","first-page":"6777","DOI":"10.1038\/s41467-021-26926-0","volume":"12","author":"M Packer","year":"2021","unstructured":"Packer M, Gyawali D, Yerabolu R, Schariter J, White P. A novel mechanism for the loss of mRNA activity in lipid nanoparticle delivery systems. Nat Commun. 2021;12(1):6777.","journal-title":"Nat Commun"},{"key":"4175_CR21","doi-asserted-by":"publisher","DOI":"10.1021\/acs.analchem.3c05539","author":"J Camperi","year":"2024","unstructured":"Camperi J, Lippold S, Ayalew L, Roper B, Shao S, Freund E, Nissenbaum A, Galan C, Cao Q, Yang F, Yu C, Guilbaud A. Comprehensive impurity profiling of mRNA: evaluating current technologies and advanced analytical techniques. Anal Chem. 2024. https:\/\/doi.org\/10.1021\/acs.analchem.3c05539.","journal-title":"Anal Chem"},{"key":"4175_CR22","doi-asserted-by":"publisher","first-page":"19590","DOI":"10.1038\/s41598-024-70680-4","volume":"14","author":"R Matthessen","year":"2024","unstructured":"Matthessen R, Van Pottelberge R, Goffin B, De Winter G. Impact of mixing and shaking on mRNA-LNP drug product quality characteristics. Sci Rep. 2024;14:19590.","journal-title":"Sci Rep"},{"issue":"3","key":"4175_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11030658","volume":"11","author":"K Swetha","year":"2023","unstructured":"Swetha K, Kotla NG, Tunki L, Jayaraj A, Bhargava SK, Hu H, Bonam SR, Kurapati R. Recent advances in the lipid nanoparticle-mediated delivery of mRNA vaccines. Vaccines (Basel). 2023;11(3): 658.","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"4175_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-023-00751-6","volume":"8","author":"L Zhang","year":"2023","unstructured":"Zhang L, More KR, Ojha A, Jackson CB, Quinlan BD, Li H, He W, Farzan M, Pardi N, Choe H. Effect of mRNA-LNP components of two globally marketed COVID-19 vaccines on efficacy and stability. Npj Vaccines. 2023;8(1): 156.","journal-title":"Npj Vaccines"},{"issue":"1","key":"4175_CR25","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12951-025-03800-5","volume":"24","author":"Y Quan","year":"2025","unstructured":"Quan Y, Yang H, Li W, Li L. mRNA vaccines: immunogenicity and quality characteristics. J Nanobiotechnology. 2025;24(1):6.","journal-title":"J Nanobiotechnology"},{"key":"4175_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2021.718753","volume":"9","author":"T Liu","year":"2021","unstructured":"Liu T, Liang Y, Huang L. Development and Delivery Systems of mRNA Vaccines. Front Bioeng Biotechnol. 2021;9: 718753.","journal-title":"Front Bioeng Biotechnol"},{"issue":"5","key":"4175_CR27","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1016\/j.ymthe.2022.02.016","volume":"30","author":"GT Szab\u00f3","year":"2022","unstructured":"Szab\u00f3 GT, Mahiny AJ, Vlatkovic I. COVID-19 mRNA Vaccines: Platforms and Current Developments. Mol Ther. 2022;30(5):1850\u201368.","journal-title":"Mol Ther"},{"issue":"11","key":"4175_CR28","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.3390\/pharmaceutics14112357","volume":"14","author":"M Kamiya","year":"2022","unstructured":"Kamiya M, Matsumoto M, Yamashita K, Izumi T, Kawaguchi M, Mizukami S, Tsurumaru M, Mukai H, Kawakami S. Stability study of mRNA-lipid nanoparticles exposed to various conditions based on the evaluation between physicochemical properties and their relation with protein expression ability. Pharmaceutics. 2022;14(11):2357.","journal-title":"Pharmaceutics"},{"issue":"1","key":"4175_CR29","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s42003-024-06235-0","volume":"7","author":"K Hashiba","year":"2024","unstructured":"Hashiba K, Taguchi M, Sakamoto S, Otsu A, Maeda Y, Ebe H, Okazaki A, Harashima H, Sato Y. Overcoming thermostability challenges in mRNA\u2013lipid nanoparticle systems with piperidine-based ionizable lipids. Commun Biol. 2024;7(1):556.","journal-title":"Commun Biol"},{"issue":"1","key":"4175_CR30","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41597-022-01167-y","volume":"9","author":"J Sun","year":"2022","unstructured":"Sun J, Zhang M, Gehl A, Fricke B, Nawaz K, Gluesenkamp K, Shen B, Munk J, Hagerman J, Lapsa M, Awwad N, Recipe C, Auyer D, Brisson D. Dataset of ultralow temperature refrigeration for COVID-19 vaccine distribution solution. Sci Data. 2022;9(1):67.","journal-title":"Sci Data"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-026-04175-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11095-026-04175-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-026-04175-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:54:31Z","timestamp":1791302071000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11095-026-04175-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["4175"],"URL":"https:\/\/doi.org\/10.1007\/s11095-026-04175-4","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,21]]},"assertion":[{"value":"9 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}